Beckman Coulter Diagnostics Appoints Kevin O'Reilly as New President
BREA, Calif., Feb. 6, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O'Reilly's appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive, Danaher Diagnostics.
- BREA, Calif., Feb. 6, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O'Reilly's appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive, Danaher Diagnostics.
- "Kevin brings more than 30 years of leadership experience, including accelerating and delivering innovation on a global scale within the healthcare industry," said Sawyer Montgomery.
- Kevin's experience running a complex operating division as president, coupled with his track record of achieving results equips him well to lead Beckman Coulter Diagnostics' next chapter."
- "Every hour around the world, more than a million clinical samples – representing up to a million people – are analyzed using Beckman Coulter Diagnostics platforms," said O'Reilly.